mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Chiaki Kawase et al.|Clinical Cancer Research|2009Cited by 155
CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathwaysKiyoko Nakamura, Masahide Ohmichi, Yoshito Terai et al.|Oncology Reports|2017Cited by 117
Vascular Endothelial Growth Factor Is a Promising Therapeutic Target for the Treatment of Clear Cell Carcinoma of the OvarySeiji Mabuchi, Tadashi Kimura, Ken‐ichirou Morishige et al.|Molecular Cancer Therapeutics|2010Cited by 88
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancerKazuya Maeda, Masahide Ohmichi, Hiroshi Sasaki et al.|Journal of Ovarian Research|2020Cited by 59
Up-Regulation of<i>c-met</i>Protooncogene Product Expression through Hypoxia-Inducible Factor-1α Is Involved in Trophoblast Invasion under Low-Oxygen TensionMasami Hayashi, Yuji Murata, Masahiro Sakata et al.|Endocrinology|2005Cited by 54